Ascendis Pharma GmbH
Records under this name other than the patents Ascendis Pharma GmbH holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 8 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,968,085 | Hydrogel Formulations Formerly held In force · High confidence | In force | High confidence | |
| US 10,098,930 | PEGylated Recombinant Human Growth Hormone Compounds Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,960,053 | PEGylated recombinant human growth hormone compounds Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,986,609 | Sterilization of Biodegradable Hydrogels Formerly held In force · High confidence | In force | High confidence | |
| US 9,919,033 | Dry growth hormone composition transiently linked to a polymer carrier Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 10,682,395 | Dry growth hormone composition transiently linked to a polymer carrier Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 12,226,457 | Dry growth hormone composition transiently linked to a polymer carrier Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 11,559,482 | Biodegradable Polyethylene Glycol Based Water-Insoluble Hydrogels Formerly held In force · High confidence | In force | High confidence | |
| US 8,906,847 | Prodrug comprising a drug linker conjugate Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 9,272,048 | PEGylated recombinant human growth hormone compounds Formerly held In force · From the USPTO record | In force | From the USPTO record |